Yuichi Iwaki
2019
In 2019, Yuichi Iwaki earned a total compensation of $3.8M as President and Chief Executive Officer at MediciNova, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $214,519 |
|---|---|
| Option Awards | $2,958,518 |
| Salary | $572,051 |
| Other | $16,800 |
| Total | $3,761,888 |
Iwaki received $3M in option awards, accounting for 79% of the total pay in 2019.
Iwaki also received $214.5K in non-equity incentive plan, $572.1K in salary and $16.8K in other compensation.
Rankings
In 2019, Yuichi Iwaki's compensation ranked 3,202nd out of 13,971 executives tracked by ExecPay. In other words, Iwaki earned more than 77.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,202 out of 13,971 | 77th |
Division Manufacturing | 1,157 out of 5,701 | 80th |
Major group Chemicals And Allied Products | 394 out of 2,200 | 82nd |
Industry group Drugs | 324 out of 1,886 | 83rd |
Industry Pharmaceutical Preparations | 240 out of 1,398 | 83rd |
Source: SEC filing on April 26, 2022.
Iwaki's colleagues
We found two more compensation records of executives who worked with Yuichi Iwaki at MediciNova in 2019.